FIGURE 1.

Dose-response curves of ExtTa and DOX. Dose-response curves of ExtTa (ethanolic extract from Trichoderma asperelloides) for non-cancer cell lines GM637, HEK-293T, mice NIH/3T3, and L929 (A). Dose-response curves of ExtTa for tumor cell lines T98G, HCT116, Saos-2, WiDr, LB373, A549, HT1080, and MDA-MB-231 (B). Dose-response curves of DOX (doxorubicin) for non-cancer human cell lines GM637, HEK-293T, murine NIH/3T3, and L929 (C). Dose-response curves for DOX for tumor cell lines T98G, HCT116, Saos-2, WiDr LB373, A549, HT1080, MDA-MB-231 (D). Values shown are the means of three independent experiments (n = 3). Dose-response curves were generated using GraphPad Prisma Version 8.0.1 software, employing a non-linear regression analysis model to obtain IC₅₀ (half-maximal inhibitory concentration of a drug) values.